Literature DB >> 20887106

Magnetic resonance imaging versus ultrasonography for the in utero evaluation of central nervous system anomalies.

Pierpaolo Peruzzi1, Rebecca J Corbitt, Corey Raffel.   

Abstract

OBJECT: The use of fetal MR imaging for the in utero evaluation of pathological conditions of the CNS is widely accepted as an adjunct to fetal ultrasonography studies. Magnetic resonance imaging is thought to characterize CNS anomalies better, and to provide a more exact diagnosis and accurate prognosis. The purpose of this study was to determine the role of and indications for fetal MR imaging in evaluating fetuses with different CNS abnormalities that were seen initially on prenatal sonograms.
METHODS: Over a 3-year period, fetuses with prior sonographic evidence of CNS abnormalities who consequently received prenatal MR imaging at Columbus Nationwide Children's Hospital within 2 weeks of the fetal ultrasonography study were included in this study. For each patient, radiological reports from both studies were reviewed, analyzed, and compared with the findings at postnatal imaging or physical examination. Results of the 2 modalities were then compared in terms of diagnostic accuracy.
RESULTS: Twenty-six fetuses were included in this study on the basis of an in utero sonogram showing a CNS anomaly. Their gestational age ranged from 17 to 35 weeks, with a mean of 25 weeks at the time of fetal ultrasonography. Hydrocephalus was identified in 16 fetuses, 6 had evidence of a spinal dysraphic defect, 2 had holoprosencephaly, 1 had an encephalocele, and 1 had multiple body abnormalities requiring detailed CNS evaluation. Twenty-five of the fetuses were correctly evaluated as having abnormal CNS findings on both fetal ultrasonography and fetal MR imaging. Fetal ultrasonography provided a correct prenatal diagnosis in 20 cases, whereas fetal MR imaging was correct in 22 cases. There were 9 cumulative false-positive results for fetal ultrasonography and 7 for fetal MR imaging, whereas for false-negative results there were a total of 34 and 19, respectively.
CONCLUSIONS: Fetal MR imaging is more sensitive in detecting fetal CNS abnormalities, but its ability to provide a correct prenatal diagnosis is only marginally superior to fetal ultrasonography. Moreover, fetal MR imaging is not exempt from misdiagnosis, and still shows a significantly high rate of false-negative results. Particularly for spinal dysraphic defects, fetal MR imaging does not seem to add important diagnostic or prognostic details when compared with fetal ultrasonography.

Entities:  

Mesh:

Year:  2010        PMID: 20887106     DOI: 10.3171/2010.7.PEDS09511

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

1.  Fetal hydrocephalus.

Authors:  Sergio Cavalheiro; Antonio Fernandes Moron; Carlos Gilberto Almodin; Italo Capraro Suriano; Vagner Hisaba; Patricia Dastoli; Mauricio Mendes Barbosa
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

2.  Diagnostic accuracy of ultrasonography and magnetic resonance imaging for the detection of fetal anomalies: a blinded case-control study.

Authors:  L F Gonçalves; W Lee; S Mody; A Shetty; H Sangi-Haghpeykar; R Romero
Journal:  Ultrasound Obstet Gynecol       Date:  2016-07-10       Impact factor: 7.299

3.  Two Cases of Craniospinal Rachischisis Totalis: Role of Magnetic Resonance Imaging in Diagnosis and Review of Neural Tube Defects in the Indian Context with Implications for Folate Fortification.

Authors:  Deepasree Jaganmohan; Prema Subramaniam; Nagarajan Krishnan; Preetam Mahajan
Journal:  J Pediatr Neurosci       Date:  2017 Jan-Mar

Review 4.  Prenatal diagnosis of spinal dysraphism.

Authors:  Liat Ben-Sira; Catherine Garel; Gustavo Malinger; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

Review 5.  A systematic review and meta-analysis to determine the contribution of mr imaging to the diagnosis of foetal brain abnormalities In Utero.

Authors:  Debbie Jarvis; Cara Mooney; Judith Cohen; Diana Papaioannou; Mike Bradburn; Anthea Sutton; Paul D Griffiths
Journal:  Eur Radiol       Date:  2016-09-21       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.